No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 1.880
- +0.060+3.30%
Close Apr 23 16:00 ET
- 1.880
- 0.0000.00%
Post 17:44 ET
128.25MMarket Cap-1074P/E (TTM)
1.950High1.810Low209.69KVolume1.850Open1.820Pre Close394.62KTurnover0.66%Turnover RatioLossP/E (Static)68.22MShares5.70052wk High0.85P/B60.00MFloat Cap1.62052wk Low--Dividend TTM31.91MShs Float63.620Historical High--Div YieldTTM7.69%Amplitude1.620Historical Low1.881Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Wedbush Reiterates Outperform on Vor Biopharma, Maintains $11 Price Target
Buy Rating Affirmed for Vor Biopharma on Clinical Progress and Market Potential
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLongeveron (NASDAQ:LGVN) stock rose 48.6% to $3.27 during Friday's after-market session. The company's market cap stands at $8.2 million. Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by
Vor Bio to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming i
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
PLAB, SMTC and WOOF Are Among After Hour Movers
Comments
ColumnsTop upgrades and downgrades on 4/27
Upgrades
• $Ares Capital Corp(ARCC.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $22
• $Avery Dennison(AVY.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $195
• $Avery Dennison(AVY.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $195 (from $215)
• $Brookfield Asset Management(BAM.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $71.50 (from $68)
• $Ecolab(ECL.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $1...
• $Ares Capital Corp(ARCC.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $22
• $Avery Dennison(AVY.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $195
• $Avery Dennison(AVY.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $195 (from $215)
• $Brookfield Asset Management(BAM.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $71.50 (from $68)
• $Ecolab(ECL.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $1...
14
$Vor Biopharma(VOR.US$ RSLs are at the bottom waiting to explode
2
$Vor Biopharma(VOR.US$ what’s wrong with this stock? going down all the wa…
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg